Latest Breaking News On - Amneal pharmaceuticals stock performance - Page 1 : comparemela.com

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6 4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […]

Piper sandlerSherbrooke park advisersNews ratings for amneal pharmaceuticals dailyAmneal pharmaceuticalsAtlanta consulting group advisorsAmneal pharmaceuticals company profileAmneal pharmaceuticals incAmneal pharmaceuticals stock performanceGoldman sachs groupInstitutional investors weigh in on amneal pharmaceuticalsGet free reportCapital managementPark advisersConsulting group advisorsBayesian capital managementAmneal pharmaceuticals daily

The Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8 00

The Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerNews ratings for amneal pharmaceuticals dailyConnor clark lunn investment management ltdHedge funds weigh in on amneal pharmaceuticalsAmneal pharmaceuticals incGoldman sachs groupAmneal pharmaceuticals stock performanceAmneal pharmaceuticalsCaxton associatesFree reportGet free reportInvestment managementLunn investment managementPublic employees retirement systemAmneal pharmaceuticals daily

Amneal Pharmaceuticals (AMRX) Buy Rating Reiterated at Truist Financial

Amneal Pharmaceuticals (AMRX) Buy Rating Reiterated at Truist Financial
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerGoldman sachs groupInstitutional investors weigh in on amneal pharmaceuticalsAmneal pharmaceuticalsAmneal pharmaceuticals stock performanceNews ratings for amneal pharmaceuticals dailyRaymond james associatesYork mellon corpPrincipal financial group incSg americas securitiesAmneal pharmaceuticals incTruist financialFree reportGet free reportNew york mellon corpFinancial group

Brokerages Set Amneal Pharmaceuticals, Inc (NASDAQ:AMRX) PT at $7 31

Brokerages Set Amneal Pharmaceuticals, Inc (NASDAQ:AMRX) PT at $7 31
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerAmneal pharmaceuticalsAmneal pharmaceuticals stock performanceNews ratings for amneal pharmaceuticals dailySherbrooke park advisersAdvisory servicesGoldman sachs groupAmneal pharmaceuticals incAmneal pharmaceuticals company profileInstitutional trading of amneal pharmaceuticalsGet free reportTruist financialCapital managementPark advisersAigen investment managementGet free

Brokerages Set Amneal Pharmaceuticals, Inc (NASDAQ:AMRX) PT at $7 31

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been given an average recommendation of “Buy” by the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have covered the […]

United statesPiper sandlerAmneal pharmaceuticals incGoldman sachs groupInstitutional investors weigh in on amneal pharmaceuticalsAmneal pharmaceuticalsConnor clark lunn investment management ltdNews ratings for amneal pharmaceuticals dailyAmneal pharmaceuticals stock performanceCaxton associatesGet free reportMarketbeat ratingsInvestment managementLunn investment managementPublic employees retirement systemGet free